Opioid Victims’ Justice in Purdue Settlement
- In 2019, purdue Pharma, the company behind OxyContin, declared bankruptcy despite having no debt and a net worth exceeding a billion dollars.
- The goal of Purdue Pharma, along with its wealthy owners, the Sackler family, was to achieve a bankruptcy settlement that would resolve thousands of lawsuits.
- Ryan Hampton, one of the 140,000 individuals who filed a claim against Purdue, shared his insights on the bankruptcy process:
“`html
Purdue Pharma’s bankruptcy: A Quest for Justice Amid the Opioid Crisis
Table of Contents
- Purdue Pharma’s bankruptcy: A Quest for Justice Amid the Opioid Crisis
- Purdue Pharma bankruptcy: Q&A on the Quest for Justice Amid the Opioid Crisis
- Understanding the Purdue Pharma Bankruptcy
- Q: Why did Purdue Pharma declare bankruptcy?
- Q: What was the goal of Purdue pharma and the Sackler family in filing for bankruptcy?
- Q: Who is Ryan Hampton, and what is his involvement in the Purdue Pharma case?
- Q: What is Ryan Hampton’s personal experience with OxyContin?
- Q: What were the key takeaways from the Sackler family’s depositions?
- The Proposed Settlement and Its Controversies
- The Plight of victims
- Key Takeaways
- Summary Table: Key Aspects of the Purdue Pharma Bankruptcy Case
- Understanding the Purdue Pharma Bankruptcy
March 9, 2025
The Billion-Dollar Bankruptcy
In 2019, purdue Pharma, the company behind OxyContin, declared bankruptcy despite having no debt and a net worth exceeding a billion dollars. This move came as the company faced trillions in claims related to its role in the devastating opioid crisis, which has claimed over 800,000 American lives.
The goal of Purdue Pharma, along with its wealthy owners, the Sackler family, was to achieve a bankruptcy settlement that would resolve thousands of lawsuits. Though, five years later, the legal battle continues, with the Sacklers still in control of Purdue Pharma and victims yet to receive any compensation.
Victims’ Voices: Ryan Hampton‘s Viewpoint
Ryan Hampton, one of the 140,000 individuals who filed a claim against Purdue, shared his insights on the bankruptcy process:
Bankruptcy’s not about justice. That’s what I learned in this process.
Ryan Hampton
He further elaborated:
It’s about money. It’s about money.It’s about who gets paid the moast and who gets paid out in what order.
Ryan Hampton
hampton recounted his personal experience with OxyContin, starting in 2003 at the age of 23 when he was prescribed the drug for a knee injury. He described receiving “an absurd amount of medication
” from his doctors.
Hampton, a former white House intern, quickly became addicted to the powerful opioid, leading to job loss and homelessness. He remembers thinking, “If this is all my life is, as long as I am able to get my fix, then I’m entirely fine with it.
” After overcoming his addiction through treatment, he became a vocal advocate against Purdue and the Sacklers and was appointed by the Justice Department in 2019 to represent victims’ financial interests.
The Sackler Family’s Depositions
In 2020, seven members of the Sackler family, all former Purdue board members or employees, were deposed as part of the bankruptcy case. Dr. Richard Sackler, former president of Purdue, acknowledged that OxyContin was the top-selling opioid at Purdue Pharma. When questioned about the risks associated with higher doses of OxyContin, he stated:
It wasn’t more risky for the patient than any other pill.
Dr. Richard Sackler
David Sackler, Richard’s son, who helped manage the family’s wealth and served on Purdue’s board, addressed Purdue’s responsibility to patients who developed opioid use disorder (OUD):
These were– these were defined risks on the label, and while we feel terrible for them, I think we’ve taken a dramatic amount of responsibility for them…
David Sackler
The Proposed Settlement and Its Discontents
In January, the Sacklers and Purdue agreed to pay up to $7.4 billion to settle the bankruptcy case, perhaps one of the largest opioid settlements ever. Though, with 140,000 claims alleging harm, only about 10% of the total amount is expected to go to victims. The remaining 90% is earmarked for creditors, including 48 states, thousands of hospitals, insurance companies, and top pharmacy chains.
Hampton criticized this distribution, stating:
It felt like every major company under the Sun– was coming for a part of Purdue.
Ryan Hampton
He further added:
The most surprising fact for me was that victims were not first in line, but last in line– becuase there were larger corporate and government interests that wanted to get paid first.
Ryan Hampton
Court records reveal that lawyers, mediators, and others have already received nearly $1 billion from Purdue. Forty-one firms have been paid more than what victims are expected to receive in the $7.4 billion deal, with senior lawyers charging as much as $2,645 an hour.
Hampton expressed his dismay:
It’s sickening.
Ryan Hampton
He also voiced his concern that many victims might not receive any payment, calling it “a kick in the gut.
“
The Plight of Victims: Emily Walden and Pete Jackson
Many victims will need to provide proof of a Purdue opioid prescription to have a valid claim. This requirement excludes families like Pete Jackson and Emily Walden, who do not expect to receive any compensation.
Walden, who lost her son TJ to an overdose 13 years ago, believes that families who paid for funerals or treatment due to Purdue’s actions should receive compensation. TJ’s death certificate lists “oxycodone” as a factor, but this may not be sufficient proof in the bankruptcy case.
Walden argued:
They knew they were making massive profits on putting these on the street. They knew that. Why would they not be held liable for that? You knew it was being diverted. And you let it go.
Emily Walden
Pete Jackson’s daughter, Emily, died in 2006 after taking OxyContin for the first time. Jackson compared OxyContin to “leaving a loaded gun on the table.
” He stated, “Emily was blindsided.She didn’t know that one pill coudl kill you.
“
Purdue Pharma bankruptcy: Q&A on the Quest for Justice Amid the Opioid Crisis
This article delves into the complex Purdue Pharma bankruptcy case, exploring the roles of the Sackler family, the struggles of victims seeking compensation, and the overall pursuit of justice within the opioid crisis.
Understanding the Purdue Pharma Bankruptcy
Q: Why did Purdue Pharma declare bankruptcy?
A: In 2019, purdue Pharma, the maker of OxyContin, declared bankruptcy due to facing trillions of dollars in claims related to its role in the opioid crisis. Despite having a net worth exceeding a billion dollars and no debt, the company sought bankruptcy protection to resolve numerous lawsuits.
purdue Pharma faced overwhelming legal claims linked to the opioid crisis.
The company aimed to negotiate a settlement to address its liabilities.
Q: What was the goal of Purdue pharma and the Sackler family in filing for bankruptcy?
A: Their primary goal was to reach a bankruptcy settlement that would resolve the thousands of lawsuits against them. As of 2025, the legal battle continues, with the Sacklers still in control of Purdue Pharma.
Q: Who is Ryan Hampton, and what is his involvement in the Purdue Pharma case?
A: Ryan Hampton is an advocate and one of the 140,000 individuals who filed a claim against Purdue Pharma. A former opioid addict, Hampton now speaks out against Purdue and the Sacklers. He was appointed by the Justice Department in 2019 to represent the financial interests of victims.
Hampton is a vocal critic of the bankruptcy process,calling it money-driven rather than justice-driven.
He argues that the bankruptcy prioritized the interests of larger corporate and government creditors over the victims.
Q: What is Ryan Hampton’s personal experience with OxyContin?
A: Hampton was prescribed OxyContin at the age of 23 for a knee injury and quickly became addicted. This led to job loss and homelessness, highlighting the drug’s highly addictive nature.
Q: What were the key takeaways from the Sackler family’s depositions?
A: During the 2020 depositions:
Dr. Richard Sackler acknowledged OxyContin was Purdue Pharma’s top-selling opioid but claimed it wasn’t riskier than any other pill.
David Sackler stated that Purdue had taken “a dramatic amount of duty” for patients who developed opioid use disorder, despite claiming the risks were defined on the label.
The Proposed Settlement and Its Controversies
Q: What were the terms of the proposed settlement between the sacklers and Purdue?
A: In January,the Sacklers and Purdue agreed to pay up to $7.4 billion to settle the bankruptcy case. However, only about 10% of this amount is expected to go to victims, with the remaining 90% earmarked for creditors.
Q: why is the proposed settlement criticized?
A: Critics, including Ryan Hampton, argue that the settlement prioritizes creditors such as states, hospitals, and insurance companies over the victims of the opioid crisis. hampton notes that many major companies are seeking a share of Purdue’s assets, leaving victims last in line for compensation.
Q: How much money have lawyers and mediators received from Purdue so far?
A: Lawyers, mediators, and others involved in the bankruptcy case have already received nearly $1 billion from Purdue. some senior lawyers have charged as much as $2,645 per hour, leading to criticism over the distribution of funds.
Q: What proof do victims need to provide to have a valid claim?
A: Many victims will need to provide proof of a Purdue opioid prescription to have a valid claim.
The Plight of victims
Q: What challenges do victims like Emily Walden and pete Jackson face in receiving compensation?
A: Some victims,like Emily Walden and Pete Jackson,may not receive compensation because they cannot provide proof of a Purdue opioid prescription. Walden,who lost her son to an overdose,believes that families who paid for funerals or treatment due to Purdue’s actions should be compensated. Pete Jackson’s daughter died after taking OxyContin for the first time.
Emily Walden’s son’s death certificate lists “oxycodone” as a factor,but it may not be sufficient proof for compensation.
Pete Jackson compared OxyContin to ”leaving a loaded gun on the table,” emphasizing that his daughter was unaware one pill could be fatal.
Key Takeaways
Q: What is the overarching sentiment regarding Purdue Pharma’s bankruptcy?
A: There is a widespread sentiment that the bankruptcy process prioritizes financial interests over justice for the victims of the opioid crisis. Many believe that larger corporate and government creditors are favored over the individuals and families who have suffered direct harm.
Q: What does the future hold for victims seeking compensation from Purdue Pharma?
A: The future remains uncertain for many victims. The proposed settlement may provide some financial relief, but the limited amount allocated to victims and the challenges in proving claims meen that many may not receive the compensation they deserve.
Summary Table: Key Aspects of the Purdue Pharma Bankruptcy Case
| Aspect | Description |
| ————————- | ————————————————————————————————————– |
| Bankruptcy Filing | Purdue Pharma declared bankruptcy in 2019 due to opioid-related lawsuits. |
| Sackler Family | Owners of Purdue Pharma, accused of prioritizing profits over public health. |
| Ryan Hampton | Victims Advocate representing victims’ financial interests. |
| Proposed Settlement | $7.4 billion settlement, with only 10% allocated to victims. |
| Creditor Prioritization | 90% of settlement funds earmarked for creditors (states, hospitals, insurance companies). |
| Victim Challenges | Difficulties in proving claims, possibly excluding families like Walden and Jackson from compensation. |
| Compensation disparity | large amounts already paid to lawyers and mediators, dwarfing potential individual victim payouts |